Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tim Dorius
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial
Credit: Foundation Medicine, Inc. When people think of cancer, they often think of diseases such as breast or lung cancer. But approximately 1 in 5 people living with cancer in the United States have been diagnosed with a rare cancer, each type affecting less than 20,000 Americans a year.1 Although some rare cancer types, such as cancer of the bile duct called cholangiocarcinoma (CCA), may be unknown to most people, rare cancers also include subsets of even the most well-known cancers.
Immunotherapy a Safe Option in Immunocompromised Patients with Advanced Skin Cancer
Skin cancer encompasses several types of cancer, including some types of melanoma. The most common type of non-melanoma skin cancer is basal-cell carcinoma. The second most common type is cutaneous squamous-cell carcinoma (or CSCC for short). Cutaneous Squamous-Cell Carcinoma In the past 3 decades, the number of cases of CSCC has been rising significantly every year in the United States.
Hope Against All Odds: My Journey with Immunotherapy for Advanced Bladder Cancer
There is nothing scarier than the words “you have cancer.” When I was first diagnosed with bladder cancer 11 years ago, it blew me away. I didn’t know how to react, because I had never been faced with such a challenge before. Stage III Bladder Cancer My doctors at Winthrop University Hospital in Garden City, Long Island, told me that I had stage III bladder cancer, and that it was very aggressive.
The Immunotherapy Surge
Issue IntroductionsImmunotherapy In this special issue focused on immunotherapy, we take a deep dive into this exciting type of treatment, highlighting the role of genetic testing and new developments in lung, skin, and bladder cancer in improving patient outcomes.
Molecular Profiling and Immunotherapy Offered Me New Hope After Stage IV Lung Cancer Diagnosis
When you reach a certain age, aches and pains often become common. That’s why, as a woman in her mid-50s, I didn’t think much of it when I woke up one day with a backache. I figured that I had overexerted myself in some way, maybe by picking up one of my grandchildren or carrying something too heavy.
Immunotherapy Brings New Hope for Patients with Non–Small-Cell Lung Cancer and PD-1/PD-L1 Biomarker - CONQUER: the patient voice
Lung cancer remains the leading cause of cancer-related death in the United States and is responsible for almost a quarter (24%) of all cancer deaths, according to the American Cancer Society. Lung cancer is divided into small-cell lung cancer and non–small-cell lung cancer, or NSCLC for short. Most lung cancers are identified as NSCLC, which accounts for about 84% of all lung cancer cases.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tim
Contact Tim, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack